Bristol-Myers Squibb $74 billion takeover of Celgene saw it shoot up the list ... off with the earlier-than-expected approval of three-drug cystic fibrosis combination Trikafta (ivacaftor ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback